CureLauncher logo — Empowering users to discover personalized medical treatments...

CureLauncher

Empowering users to discover personalized medical treatments from Bloomfield Hills, Michigan.

Founded 2012 11-50 employees Series B Total: $1.30M Biotechnology, Health Care

General Information

Company Name CureLauncher
Founded Year 2012
Founders / Decision Makers
Team member
Employees 11-50
Industries Biotechnology, Health Care
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with CureLauncher. To contact CureLauncher, visit curelauncher.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does CureLauncher compare?

A PDF of CureLauncher and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting CureLauncher soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About CureLauncher

CureLauncher is a biotechnology and health care startup based in Bloomfield Hills, Michigan. Founded in 2012, the company's slogan "Empowering users to discover personalized medical treatments" reflects its core mission to enable users to find suitable medical treatments based on their conditions. In September 2014, CureLauncher secured a $500.00K Series B investment from Ann Arbor Spark and IncWell. This funding signifies a significant milestone in the company's growth and underscores investor confidence in its potential to revolutionize personalized medical treatment discovery.

Business keywords: Medical treatments, Clinical trials, Patient support, Personalized medicine, Patient advocacy, Healthcare innovation, Healthcare solutions

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series B $500.00K 2
Ann Arbor Spark, IncWell
12 Sep 2014
Debt Financing $50.00K -
02 Jul 2014
Series A $750.00K 1
IncWell
01 Jun 2013

CureLauncher Alternatives & Competitors

View All Alternatives
CureLauncher vs

Harness the power of respiratory-based treatment for hypertension and heart failure with innovative...

Post-IPO Equity
Biotechnology, Health Care
CureLauncher vs
Harmony Biosciences
Harmony Biosciences United States

A fresh approach to helping patients thrive.

Post-IPO Debt
273 employees
Biopharma, Biotechnology
CureLauncher vs

Cancer drug development comes of age.

Post-IPO Equity
190 employees
Biopharma, Biotechnology

FAQ About CureLauncher

Empowering users to discover personalized medical treatments from Bloomfield Hills, Michigan.
CureLauncher was founded in 2012.
CureLauncher operates in Biotechnology and Health Care. Its work centres on Medical treatments, Clinical trials, Patient support and Personalized medicine.
CureLauncher has approximately 11-50 employees.
CureLauncher has completed 3 funding rounds, raising a total of $1.30M. The latest funding stage is Series B.
Top alternatives and competitors to CureLauncher include InterCure, Harmony Biosciences, Day One Biopharmaceuticals, Sano Genetics, Phoenix Molecular Designs. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CureLauncher and InterCure are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for CureLauncher, https://bouncewatch.com/company/curelauncher, updated 20 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes